Evidence map›Paper›PMID 20043860›Full record

ArticleBMC bioinformatics2010

Detection of gene pathways with predictive power for breast cancer prognosis.

Shuangge Ma, Michael R Kosorok

Abstract read
In one paragraph

Article in BMC bioinformatics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shuangge MaSchool of Public Health, Yale University, New Haven, CT 06520, USA. shuangge.ma@yale.edu
Michael R Kosorok

Funding

Semiparametric and Empirical Process Methods in OncologyR01CA075142 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOSOROK, MICHAEL R · 2002 to 2008
$1.1M
MULTIVARIATE GROUP SEQUENTIAL CANCER CLINICAL TRIALSR29CA075142 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI KOSOROK, MICHAEL R · 1997 to 2001
$197k
Efficient microarray meta analysis and cancer biomarker selectionR03LM009828 · NLM · YALE UNIVERSITY · PI MA, SHUANGGE · 2008 to 2009
$175k
Effective clustering penalized methods for genomic biomarker selectionR03LM009754 · NLM · YALE UNIVERSITY · PI MA, SHUANGGE · 2009 to 2010
$174k
NCI NIH HHS CA075142NCI NIH HHS R01 CA075142NLM NIH HHS LM009754NLM NIH HHS LM009828
6 · The paper itself

Abstract

backgroundPrognosis is of critical interest in breast cancer research. Biomedical studies suggest that genomic measurements may have independent predictive power for prognosis. Gene profiling studies have been conducted to search for predictive genomic measurements. Genes have the inherent pathway structure, where pathways are composed of multiple genes with coordinated functions. The goal of this study is to identify gene pathways with predictive power for breast cancer prognosis. Since our goal is fundamentally different from that of existing studies, a new pathway analysis method is proposed.

resultsThe new method advances beyond existing alternatives along the following aspects. First, it can assess the predictive power of gene pathways, whereas existing methods tend to focus on model fitting accuracy only. Second, it can account for the joint effects of multiple genes in a pathway, whereas existing methods tend to focus on the marginal effects of genes. Third, it can accommodate multiple heterogeneous datasets, whereas existing methods analyze a single dataset only. We analyze four breast cancer prognosis studies and identify 97 pathways with significant predictive power for prognosis. Important pathways missed by alternative methods are identified.

conclusionsThe proposed method provides a useful alternative to existing pathway analysis methods. Identified pathways can provide further insights into breast cancer prognosis.

Indexed as

Biomarkers, TumorBreast NeoplasmsComputational BiologyFemaleGene Expression ProfilingGenetic Predisposition to DiseaseHumansPrognosisSignal TransductionBiomarkers, Tumor

Identifiers

PMID20043860
PMCPMC2837025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.